Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy ― The HORIZON-HCM Study ―Hiroaki Kitaoka, Chisato Izumi, Tetsuya Watanabe et al.|Circulation Journal|2024Cited by 23
Contemporary clinical characteristics and management patterns in hypertrophic cardiomyopathy: insights from baseline enrolment data in a nationwide prospective Japanese registryToru Kubo, Hiroaki Kitaoka, Miki Tsujiuchi et al.|Heart|2025Cited by 3